Fatigue News and Research

RSS

FDA approves drug for rare, hard-to-treat types of non-Hodgkin lymphoma

The U.S. Food and Drug Administration today approved Poteligeo (mogamulizumab-kpkc) injection for intravenous use for the treatment of adult patients with relapsed or refractory mycosis fungoides or Sézary syndrome after at least one prior systemic therapy.

8 Aug 2018

Study: Indian-Americans have lowest rate of sudden unexpected infant deaths

Indian-Americans have the highest percentage of sleeping with their babies among ethnic groups in New Jersey but the lowest rate of sudden unexpected infant death, a Rutgers Biomedical and Health Sciences study shows.

7 Aug 2018

Researchers identify role of infection-fighting cells in inflamed and damaged tissue

Hookworms infect nearly 430 million people in the world, mostly in countries where sanitation is poor, and people often walk barefoot.

7 Aug 2018

Sleep timing and quality can influence dietary behaviors of school-aged children

From toddlers to teens, every parent knows that children can sometimes be fickle eaters. Yet, few would know that a child's bedtime and how well they sleep at night can also affect how well they eat.

7 Aug 2018

Doctors reckon with high rate of suicide in their ranks

Alarms go off so frequently in emergency rooms, doctors barely notice. And then a colleague is wheeled in on a gurney, clinging to life, and that alarm becomes a deafening wake-up call.

3 Aug 2018

Regenacy Pharmaceuticals partners with CMTA to advance ricolinostat for treating hereditary neuropathy

Regenacy Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other peripheral neuropathies, today announced a collaboration with the Charcot-Marie-Tooth Association, a registered non-profit organization serving the hereditary neuropathy patient community, to validate the role of HDAC6 in multiple forms of Charcot-Marie-Tooth disease and evaluate the efficacy of ricolinostat, a selective HDAC6 inhibitor, in animal models.

2 Aug 2018

Palliative care offers extra layer of support while dealing with cancer

When you or a loved one is diagnosed with cancer, it is normal to be overwhelmed by thoughts of prognosis, treatments, and potential complications. Patients wonder how their lives are going to change and whether their quality of life will ever return to normal.

2 Aug 2018

Researchers explore influence of dietary nitrate on cognitive function in veterans with GWI

Glenn Wylie, DPhil, and Jorge Serrador, PhD, have won an award from the Rutgers Brain Health Institute. The grant funds a collaborative study between the Department of Pharmacology, Physiology, and Neuroscience at Rutgers New Jersey Medical School and Kessler Foundation.

1 Aug 2018

FDA approves first therapy for patients with rare tumors of the adrenal gland

The U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or paraganglioma) that cannot be surgically removed (unresectable), have spread beyond the original tumor site and require systemic anticancer therapy.

31 Jul 2018

New findings suggest opportunity to focus on safe opioid use and disposal among older adults

Nearly a third of older adults have received a prescription for an opioid pain medicine in the past two years, but many of them didn't get enough counseling about the risks that come with the potent painkillers, how to reduce their use, when to switch to a non-opioid option, or what to do with leftover pills, a new poll finds.

30 Jul 2018

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Tafinlar® in combination with Mekinist® for the adjuvant treatment of adult patients with stage III melanoma with a BRAF V600 mutation, following complete resection.

27 Jul 2018

Therapy with L-Glutamine reduces pain in patients with sickle cell disease

UCSF Benioff Children's Hospital Oakland clinical researchers, in conjunction with other sickle cell centers and scientists at Emmaus Life Sciences, Inc., have demonstrated that therapy with L-Glutamine reduced the frequency of pain episodes in both pediatric and adult patients with sickle cell disease.

27 Jul 2018

CNDA approves KEYTRUDA for treatment of advanced melanoma

Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.

26 Jul 2018

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck, known as MSD outside the United States and Canada, announced today that the pivotal Phase 3 KEYNOTE-048 trial investigating KEYTRUDA, Merck's anti-PD-1 therapy, for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma, met a primary endpoint of overall survival as monotherapy in patients whose tumors expressed PD-L1.

25 Jul 2018

Fitness trackers can be valuable tools for monitoring cancer patients, finds study

Fitness trackers can be valuable tools for assessing the quality of life and daily functioning of cancer patients during treatment, a new study has found.

25 Jul 2018

UC San Diego researchers awarded two grants for investigating stem cell-based therapies

The governing board of the California Institute for Regenerative Medicine unanimously approved this week two grants worth more than $2.2 million to University of California San Diego School of Medicine researchers investigating stem cell-based therapies for a rare genetic disorder that affects the heart and a chronic, progressive affliction of the lungs.

20 Jul 2018

FDA approves first drug for treatment of adult AML patients with specific genetic mutation

The U.S. Food and Drug Administration today approved Tibsovo (ivosidenib) tablets for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation.

20 Jul 2018

Early surgical intervention may improve outcomes for patients with mitral valve disease

The number of patients undergoing mitral valve operations are at an all-time high, and new research posted online today in The Annals of Thoracic Surgery suggests that many patients don't undergo surgical intervention until it's too late to completely reverse damage caused by mitral valve disease.

19 Jul 2018

FDA grants approval for first breast cancer drug through 'Real-Time Oncology Review'

The U.S. Food and Drug Administration today approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer, as initial endocrine-based therapy.

19 Jul 2018

Study highlights potential of fetal gene therapy to prevent lethal neurodegenerative disease

A fatal neurodegenerative condition known as Gaucher disease can be prevented in mice following fetal gene therapy, finds a new study led by UCL, the KK Women's and Children's Hospital and National University Health System in Singapore.

16 Jul 2018

Fatigue News and Research

FDA approves drug for rare, hard-to-treat types of non-Hodgkin lymphoma

Study: Indian-Americans have lowest rate of sudden unexpected infant deaths

Researchers identify role of infection-fighting cells in inflamed and damaged tissue

Sleep timing and quality can influence dietary behaviors of school-aged children

Doctors reckon with high rate of suicide in their ranks

Regenacy Pharmaceuticals partners with CMTA to advance ricolinostat for treating hereditary neuropathy

Palliative care offers extra layer of support while dealing with cancer

Researchers explore influence of dietary nitrate on cognitive function in veterans with GWI

FDA approves first therapy for patients with rare tumors of the adrenal gland

New findings suggest opportunity to focus on safe opioid use and disposal among older adults

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Therapy with L-Glutamine reduces pain in patients with sickle cell disease

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Fitness trackers can be valuable tools for monitoring cancer patients, finds study

UC San Diego researchers awarded two grants for investigating stem cell-based therapies

FDA approves first drug for treatment of adult AML patients with specific genetic mutation

Early surgical intervention may improve outcomes for patients with mitral valve disease

FDA grants approval for first breast cancer drug through 'Real-Time Oncology Review'

Study highlights potential of fetal gene therapy to prevent lethal neurodegenerative disease

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News